GSS EU Science Funding Gateway

This action should cover the ambition of the sixth flagship of the Europe’s Beating Cancer Plan, the ‘Cancer diagnostic and treatment for all’ initiative. It will build on the results of the EU4Health Programme funded projects, such as the Personalised Cancer Medicine for all EU citizens (‘PCM4EU’), the EU Cancer and Public Health Genomics platform project (‘CAN.HEAL’), as well as the project for improved diagnostics and survival for all children with Acute Myeloid and the Leukaemia treated within the NOPHO-DB- SHIP consortium; a cross-European collaboration (‘CHIP-AML22’). The action will also make use of the guidelines, protocols and best practices, developed under other European Commission funded initiatives and projects such as the 1+ Million Genomes Initiative, a European-wide foundation to accelerate Data-driven Cancer Research (EOSC4Cancer), and Partnership on Transforming Health and Care Systems (THCS) as well as Innovative Health Initiative (IHI)funded projects could also be considered.

Activities will contribute to the Joint Action on Personalized Cancer Medicine’, and include:

• the implementation of targeted projects involving civil society organisations and industry complementing the Member States’ efforts in the design, planning and implementation of best practices (e.g., on metastatic cancer);
• the production of public health guidelines concerning personalised cancer medicine, genomic testing/screening and metastatic cancer management;
• patients and caregivers consultations, and other actions that can benefit citizens directly;
• preparation and roll out of innovative practices;
• support capacity building actions such as training and twinning, health communication or health literacy.

Activities should also include an equity dimension and aim at reducing health inequalities.